Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Panitumumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Panitumumabmarket, defines the market attractiveness level of Panitumumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Panitumumab industry, describes the types of Panitumumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Panitumumab market and the development prospects and opportunities of Panitumumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Panitumumab market in Chapter 13.
By Player:
Amgen
By Type:
100 mg/5 mL single-dose vials
400 mg/20 mL single-dose vials
By End-User:
Hospital
Drug Stores
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Panitumumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Panitumumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Panitumumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Panitumumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Panitumumab Market Analysis and Outlook to 2022
-
7.1 Global Panitumumab Consumption (2017-2022)
-
7.2 United States Panitumumab Consumption (2017-2022)
-
7.3 Europe Panitumumab Consumption (2017-2022)
-
7.4 China Panitumumab Consumption (2017-2022)
-
7.5 Japan Panitumumab Consumption (2017-2022)
-
7.6 India Panitumumab Consumption (2017-2022)
-
7.7 South Korea Panitumumab Consumption (2017-2022)
8 Region and Country-wise Panitumumab Market Analysis and Outlook to 2028
-
8.1 Global Panitumumab Consumption Forecast (2022-2028)
-
8.2 United States Panitumumab Consumption Forecast (2022-2028)
-
8.3 Europe Panitumumab Consumption Forecast (2022-2028)
-
8.4 China Panitumumab Consumption Forecast (2022-2028)
-
8.5 Japan Panitumumab Consumption Forecast (2022-2028)
-
8.6 India Panitumumab Consumption Forecast (2022-2028)
-
8.7 South Korea Panitumumab Consumption Forecast (2022-2028)
9 Global Panitumumab Market Outlook by Types and Applications to 2022
-
9.1 Global Panitumumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100 mg/5 mL single-dose vials Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 400 mg/20 mL single-dose vials Consumption and Growth Rate (2017-2022)
-
9.2 Global Panitumumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug Stores Consumption and Growth Rate (2017-2022)
10 Global Panitumumab Market Outlook by Types and Applications to 2028
-
10.1 Global Panitumumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 100 mg/5 mL single-dose vials Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 400 mg/20 mL single-dose vials Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Panitumumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
11 Global Panitumumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Panitumumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Panitumumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Panitumumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Panitumumab Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Panitumumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Panitumumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Panitumumab
-
Figure Panitumumab Picture
-
Table Global Panitumumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Panitumumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Panitumumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Panitumumab Consumption by Country (2017-2022)
-
Figure United States Panitumumab Consumption and Growth Rate (2017-2022)
-
Table Europe Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure China Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure India Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Global Panitumumab Consumption Forecast by Country (2022-2028)
-
Figure United States Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100 mg/5 mL single-dose vials Consumption and Growth Rate (2017-2022)
-
Figure Global 400 mg/20 mL single-dose vials Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global 100 mg/5 mL single-dose vials Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 400 mg/20 mL single-dose vials Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Panitumumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Panitumumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Panitumumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Panitumumab Product and Service
-
